Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study)

The American Journal of Cardiology
Manesh R PatelAPEX-AMI Investigators

Abstract

We evaluated the use and outcomes of drug-eluting stents (DESs) and bare metal stents (BMSs) in a large primary percutaneous coronary intervention (PCI) acute ST-elevation myocardial infarction (MI) trial. Recently concerns have been raised with "off-label" use of DESs for short- and long-term clinical outcomes. Limited randomized data exist evaluating DESs versus BMSs in ST-elevation MI. Patients (n=5,745) in the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial were categorized by stent type used. Baseline variables and clinical outcomes were collected at 90 days and 6 months. Outcomes by stent type were adjusted for using conventional multivariable predictors of 90-day mortality (age, anterior location, total ST-segment deviation, and Killip class), time to PCI, and Thrombolysis In Myocardial Infarction grade flow. Stents were deployed (at the investigator's discretion) in 5,124 patients (89.2%) with acute MI, with DES use in 2,221 (43.3%) and BMS use in 2,903 (56.7%). Patients receiving DESs were younger (median 59 vs 63 years of age, p<0.001), had left anterior descending coronary artery PCI (57.9% vs 48.1%, p<0.001), and often were treated in the United States (58.2%). DES-treated patients had a lo...Continue Reading

References

May 5, 2005·JAMA : the Journal of the American Medical Association·Marco ValgimigliUNKNOWN STRATEGY Investigators
Sep 15, 2006·The New England Journal of Medicine·Christian SpauldingUNKNOWN TYPHOON Investigators
Sep 15, 2006·The New England Journal of Medicine·Gerrit J LaarmanMark Patterson
Sep 15, 2006·The New England Journal of Medicine·Frans Van de Werf
Dec 7, 2006·JAMA : the Journal of the American Medical Association·Eric L EisensteinRobert M Califf
Feb 14, 2007·The New England Journal of Medicine·Bo LagerqvistUNKNOWN SCAAR Study Group
Feb 14, 2007·The New England Journal of Medicine·Adnan KastratiAlbert Schömig
Feb 14, 2007·The New England Journal of Medicine·Gregg W StoneMartin B Leon
Feb 14, 2007·The New England Journal of Medicine·Christian SpauldingPatrick W Serruys
Feb 14, 2007·The New England Journal of Medicine·William H Maisel
Apr 25, 2007·American Heart Journal·Vincenzo PasceriGermano Di Sciascio
May 10, 2007·JAMA : the Journal of the American Medical Association·Htut K WinUNKNOWN EVENT Registry Investigators
May 10, 2007·JAMA : the Journal of the American Medical Association·Robert A Harrington, E Magnus Ohman
May 15, 2007·Journal of the American College of Cardiology·Maurizio MenichelliRoberto Violini

❮ Previous
Next ❯

Citations

Sep 21, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Artur DziewierzDariusz Dudek
Mar 30, 2010·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Edo KaluskiMarc Klapholz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.